|
|
|
Ÿũ·Îº§Ä¸½¶1mg(Ÿũ·Î¸®¹«½º¼öȹ°) Tacrobell Cap. 1mg
|
Àü¹®ÀǾàÇ° | ±Þ¿©
|
|
| °íÀ§Çè¾à¹°
|
|
|
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàÇ° ÀÎÅÍ³Ý ÆǸŸ¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
¹é»ö ¶Ç´Â ¹Ì¹é»öÀÇ ºÐ¸»ÀÌ µé¾îÀÖ´Â Èò»öÀÇ °æÁúĸ½¶Á¦ |
|
|
|
|
Á¦Á¶È¸»ç |
(ÁÖ)Á¾±Ù´ç
|
ÆǸÅȸ»ç |
(ÁÖ)Á¾±Ù´ç
|
Çã°¡Á¤º¸ |
Á¤»ó
(2004.07.27)
|
BIT ¾àÈ¿ºÐ·ù |
¸é¿ª¾ïÁ¦Á¦ (Immunosuppressants)
|
º¹ÁöºÎºÐ·ù |
142[ÀÚ°Ý¿ä¹ýÁ¦(ºñƯÀ̼º¸é¿ª¿øÁ¦Á¦¸¦ Æ÷ÇÔ) ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
643303700[A01207401] Àú°¡¾à ´ëü Àμ¾Æ¼ºê Áö±Þ ´ë»ó \2,744 ¿ø/1ĸ½¶(2024.07.01)(ÇöÀç¾à°¡)\2,832 ¿ø/1ĸ½¶(2022.01.01) (º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
Tacrolimus / L04AD02 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]
|
÷°¡Á¦ |
±Û¸®¼¼¸±º£Çì³×ÀÌÆ®,
¶ó¿ì¸±È²»ê³ªÆ®·ý,
¹«¼öÀ¯´ç,
¹«¼öÀλê¼ö¼ÒÄ®½·,
½ºÅ׾Ƹ£»ê¸¶±×³×½·,
ÀÚ´çÁö¹æ»ê¿¡½ºÅ׸£,
ĸ½¶±âÁ¦,
Å©·Î½ºÄ«¸£¸á·Î¿À½º³ªÆ®·ý,
Ǫ¸¶¸£»ê½ºÅ׾Ƹ±³ªÆ®·ý,
È÷µå·Ï½ÃÇÁ·ÎÇʼ¿·ê·Î¿À½º,
È÷ÇÁ·Î¸á·Î¿À½º2910
|
|
|
|
|
|
|
|
|
|
Ç× ¸ñ |
³» ¿ë |
|
ºÎÀÛ¿ëºóµµ ¹× ´ëó¹ý |
[À¯·á] |
|
|
|
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-12-05 |
|
|
|
|
|
|
|
|